OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis	82
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence	67
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study	64
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer	55
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment	48
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA	41
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects	35
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma	34
Polygenic and Network-based studies in risk identification and demystification of cancer	32
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer	31
Gene fusions in vascular tumors and their underlying molecular mechanisms	29
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer	28
Cost analyses for malaria molecular diagnosis for research planners in India and beyond	28
Nuclease activity: an exploitable biomarker in bacterial infections	27
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling	27
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features	25
What makes a « good » companion diagnostic in thoracic oncology?	25
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination	25
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma	24
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome	24
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology	23
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?	22